Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
HDT Bio Corp v. Emcure Pharmaceuticals Ltd
Case Number:
2:22-cv-00334
Court:
Nature of Suit:
Defend Trade Secrets Act (of 2016)
Judge:
Firms
Companies
Sectors & Industries:
-
February 13, 2024
Indian Pharma Co. Can't Get Fees In $950M COVID Vax Suit
A Seattle federal judge has nixed an Indian generic-drug maker's bid for about $3 million in attorney fees after it prevailed in a biotherapy company's $950 million lawsuit accusing it of stealing its COVID-19 vaccine, saying the maker didn't convince him it spent extra money litigating the suit.
-
December 19, 2023
Emcure Seeks Fees After $950M Vax Trade Secrets Suit Nixed
Indian generic-drug maker Emcure Pharmaceuticals Ltd. is now seeking more than $3.2 million in attorney fees after convincing a Washington federal judge to toss on jurisdictional grounds Seattle-based HDT Bio Corp.'s $950 million lawsuit accusing it of stealing its COVID-19 vaccine.
-
December 04, 2023
Wash. Judge Nixes HDT's $950M mRNA Vax Trade Secrets Suit
A Washington federal judge has thrown out Seattle-based biotechnology company HDT Bio's nearly billion-dollar lawsuit accusing an Indian pharmaceutical firm of ripping off its mRNA platform to develop a new COVID-19 vaccine, at least for now, a docket entry showed Monday.
-
October 26, 2023
Emcure Again Looks To Toss HDT's $950M Trade Secrets Suit
An Indian pharmaceutical company again urged a Washington federal judge to throw out Seattle-based HDT Bio Corp.'s $950 million suit accusing it of stealing trade secrets, claiming in its Thursday request that the dispute is duplicative of an ongoing arbitration in London.
-
September 22, 2023
Drug Co. Again Seeks Toss Of $950M Vax Trade Secrets Case
Indian pharmaceutical company Emcure again urged a federal judge to toss a $950 million suit over allegedly stolen trade secrets from a small Washington company, arguing in a court filing Friday that it has no business presence in Washington state or anywhere in the U.S.
-
August 01, 2022
Judge Won't Toss $950M COVID-19 Vax Trade Secrets Row
A Seattle federal judge has ruled that it's too soon to decide whether an Indian generic-drug maker can use its minimal connections to the U.S. to ditch a $950 million suit over allegedly stolen trade secrets from a small American company with a proprietary mRNA platform to develop a new COVID-19 vaccine in India.
-
May 13, 2022
Drugmaker Wants $950M Vaccine Trade Secrets Suit Tossed
India-based Emcure said Friday that it shouldn't have to face a suit launched in Washington federal court claiming it stole secrets for a new COVID-19 vaccine, saying Washington state isn't the right place for the claims.
-
March 21, 2022
Drug Maker Stole COVID Vax Trade Secrets, $950M Suit Claims
A Seattle biopharmaceutical company sued India-based Emcure in Washington federal court on Monday, claiming the generic-drug maker stole its secrets for a new COVID vaccine with a proprietary mRNA platform and should pay more than $950 million in damages.